Evidence map›Paper›PMID 37417093›Full record

ArticleLung India : official organ of Indian Chest Society

Community-Acquired burkholderia cepacia complex (BCC) pneumonia in a lung cancer patient on erlotinib.

Prasanta Raghab Mohapatra, Rohit Bicaro Shirgaonkar, Bijayini Behera, Aswathy Girija

Open access · diamondAbstract read
In one paragraph

Article in Lung India : official organ of Indian Chest Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Prasanta Raghab MohapatraDepartment of Pulmonary Medicine and Critical Care, All India Institute of Medical Science-Bhubaneswar, Odisha, India.
Rohit Bicaro ShirgaonkarDepartment of Pulmonary Medicine and Critical Care, All India Institute of Medical Science-Bhubaneswar, Odisha, India.
Bijayini BeheraDepartment of Microbiology, All India Institute of Medical Science-Bhubaneswar, Odisha, India.
Aswathy GirijaDepartment of Pulmonary Medicine and Critical Care, All India Institute of Medical Science-Bhubaneswar, Odisha, India.
Creative Commons · USAll India Institute of Medical Sciences Bhubaneswar · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Community-acquired Burkholderia cepacia pneumonia is uncommon. We report a 32-year-old female who was on oral erlotinib, a tyrosine kinase inhibitor, for 2 years for her lung cancer and developed community-acquired Burkholderia cepacia pneumonia, which was confirmed by blood culture. The patient improved with antibiotics.

Indexed as

Burkholderia cepacia complex (BCC)erlotiniblung cancerpneumonia

Identifiers

PMID37417093
PMCPMC10401989
OpenAlexW4381989180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.